Resistance takes various forms including tumor-intrinsic, such as impaired MHC expression, or tumor-extrinsic usually involving the immune system, such as accumulation of immuno-suppressive cells and factors within the tumor microenvironment (TME) (Bagchi et al, 2021; Sharma et al, 2023). Here, HLA-C is linked to neoplasm.